Jasti, P., Kumari, S., Singh, S., & Anudeep, P. (2023). Serum versican as a potential biomarker in patients with uterine fibroids: A study from Eastern India. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationJasti, Pratima, Suchitra Kumari, Sweta Singh, and PP Anudeep. Serum Versican as a Potential Biomarker in Patients with Uterine Fibroids: A Study from Eastern India. Wolters Kluwer Medknow Publications, 2023.
MLA (9th ed.) CitationJasti, Pratima, et al. Serum Versican as a Potential Biomarker in Patients with Uterine Fibroids: A Study from Eastern India. Wolters Kluwer Medknow Publications, 2023.
Warning: These citations may not always be 100% accurate.